HTLV-I associated uveitis (HAU) is an inflammatory disease of ,the uvea that is associated with human T cell lymphotropic virus type 1 (HTLV-I).' Epidemiological and clinical studies have revealed that the disease is more prevalent in endemic areas of the retrovirus,' ' and that its clinical picture is characterised by the following factors. (1) Middle aged adults of either sex infected with HTLV-I present with acute, granulomatous, or non-granulomatous uveal involvements. (2) Inflammatory lesions are usually mild or moderate, resolve in a few weeks in response to corticosteroids, and result in favourable visual outcome. ( 3) The disease affects one or both eyes, and it is recurrent in about half of cases. (4) The disease may develop as an isolated ocular disorder, or it is accompanied by HTLV-I associated myelopathy that is a distinct neurological disease caused by HTLV-I. 4 The majority of HTLV-I infected individuals remain asymptomatic throughout life, and the prevalence of HAU is estimated to be about one in 1000-2000 HTLV-I carriers.6 Therefore, particularly in endemic areas, coincidence of HTLV-I infection is possible among patients with other distinct uveitis entities. Furthermore, diagnosis of HAU is on the basis of exclusion of other aetiologies, together with presence of serum antibodies to HTLV-I; elaborate laboratory assessment of affected aqueous humour to study local synthesis of HTLV-I antibodies7 or HTLV-I infected lymphocytes8 9 is usually not acceptable because of the mild nature of the disease. It is, therefore, justified to elucidate whether there is any clinical marker that may provide a diagnostic aid for HAU. We report here characteristic, grey-white, granular deposits that are scattered on the major retinal vessels and on the vitreoretinal interface over the foveolar area.
Patients and methods
We reviewed a consecutive series of 55 patients with HAU who were seen between January 1988 and June 1995 at the Kagoshima University Hospital, located in the southwestern area of Japan, in which HTLV-I is highly endemic. These cases were diagnosed as HAU, since they had serum antibodies to HTLV-I and any other uveitis entities were excluded by means of a battery of systemic and laboratory examinations. Ocular examination consisted of full physical and ophthalmic history, applanation tonometry, slit-lamp biomicroscopy with a three mirror contact lens, and binocular ophthalmoscopy. A fluorescein fundus angiogram was obtained in selected patients after receiving informed consent.
Results
A series of 55 patients with HAU showed acute, mild to moderate, granulomatous, or non-granulomatous inflammatory lesions, which involved predominantly the anterior uvea. Eight patients (14.5%) of the series were remarkable in that they showed, in addition to inflammatory signs in the anterior uvea, such characteristic changes in the retinal vasculatures as those described below. Their clinical data are summarised in Table 1 .
The eight patients, four males and four females, developed ocular disease as adults (mean age 39 years; range 20-61 years). Laboratory tests for uveitis were unremarkable, except for serum antibodies to HTLV-I. Three cases had an isolated ocular disease, and the other five cases were affected with HTLV-I associated myelopathy or hyperthyroidism for which the retrovirus is thought to play an underlying role.5 '0 These patients complained of acute floaters or blurred vision, and presented with mild, granulomatous inflammatory lesions in the Table 1 . Numerous grey-white granular materials are deposited on the surface of retinal vessels and retina. Similar depositions are also clustered on the foveola (arrow).
The retinal vascular deposits as well as uveal inflammations resolved over 1-4 weeks spontaneously or in seeming response to corticosteroids, leaving no clinical trace. The ocular disease occurred unilaterally or bilaterally. Two of the eight cases had recurrent ocular disease during a follow up period over 3 years; each episode was similar to that in the initial event.
It should be noted that the characteristic depositions on the retinal vessels, mentioned above, were not observed in any of 318 patients, with various distinct uveitis entities or aetiologically undefined uveitis, who were seen by the present authors during the same period.
REPORT OF CASES
Case 1 A 28-year-old woman, who had suffered from HTLV-I associated myelopathy beginning as early as 11 years old, presented with a 2 week history of blurred vision in the right eye. Corrected visual acuity was 0.7 in the right eye. Minimum inflammatory cells were present in the anterior chamber. The anterior chamber angle was unremarkable, and intraocular pressure was normal. There were grey-white strands extended from the optic disc and a few granular opacities in the posterior vitreous cavity. Numerous grey-white granular materials were found to deposit on the posterior retina, most prominent on the surface of retinal veins and arteries (Fig 1) . Topical corticosteroids were administered, and 2 weeks later the retinal vessel lesions as well as anterior uveal reactions resolved almost completely.
Case 2 A 46-year-old man presented with a 2 week history of floaters in both eyes, preceded by slight fever. On examination, he appeared physically normal. Corrected visual acuity was 0.9 in the right eye and 0.2 in the left. There were grey-white granular keratic precipitates and inflammatory cells in the anterior chambers, with normal anterior chamber angles and intraocular pressures. There were a few granular opacities in the posterior vitreous cavity. Fundus examination revealed deposition of grey-white granular material on slightly distended retinal veins and arteries in the HTLV-I associated uveitis Table 1 . In both eyes, there are depositions ofgrey-white granules on the slightly dilated retinal vessels in the posteriorfundus (arrowhead). Deposition of a relatively large granule on the fovea is also seen (arrow). White ring around the fovea is a photographic artefact.
posterior fundus and on the vitreoretinal interface over the centre of the fovea. The retinochoroid was otherwise unremarkable (Fig 2) . The anterior uveal inflammations and granular materials over retinal vessels resolved after 1 week's topical corticosteroids. Ophthalmoscopy revealed grey-white, discrete granules deposited on dilated retinal vessels in the posterior pole. At the vitreoretinal interface corresponding to the foveola, there were small white granules, similar in colour, contour, and shape to those on the retinal vessels (Fig 3A) . Fluorescein angiography revealed a minimum staining of the posterior retinal veins with dot hypofluorescence corresponding to the greywhite deposits (Fig 3B) . The patient was treated with systemic corticosteroids. Four weeks later, the anterior uveal inflammatory signs and retinal vascular changes had disappeared (Fig 3C) .
Discussion
The clinical features of HAU are not disease specific as reported previously,4 I so that evidence for serum antibodies to HTLV-I does not readily lead to a definite diagnosis, in particular in such endemic areas as southern Japan. In fact, we have experienced not a few patients with distinct uveitis entities, such as Behnet's disease, who had a coincident infection with HTLV-I.' Moreover, specific laboratory tests to examine local synthesis of antibodies to HTLV-I or to prove presence of HTLV-I infected T lymphocytes in the aqueous humour are not feasible, because the disease is mild to moderate with resolution in a few weeks and hence informed consent for aspiration of the aqueous humour is rarely obtained. It is, therefore, possible that, al- Figure 3 Case 3 in Table 1 
